Clinical Approach to Seizure
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of seizures
Seizures represent one of the most common neurological emergencies encountered in primary care and emergency settings. Approximately 8 to 10 percent of the general population will experience at least one seizure during their lifetime, with the highest incidence occurring in children under 1 year of age and adults over 55 years. A first unprovoked seizure occurs in approximately 50 per 100,000 persons annually. In the family medicine setting, distinguishing a true seizure from seizure mimics, identifying the underlying cause, and determining which patients require urgent referral are critical skills that directly impact patient outcomes.
Definition
A seizure is a transient occurrence of signs and symptoms resulting from abnormal, excessive, or synchronous neuronal activity in the brain. A convulsion specifically refers to a seizure with prominent motor manifestations (rhythmic jerking movements). Epilepsy is defined as two or more unprovoked seizures occurring more than 24 hours apart, OR one unprovoked seizure with a high probability of recurrence (greater than 60% over the next 10 years), OR diagnosis of an epilepsy syndrome.
Classification by Seizure Type (ILAE 2017)
The International League Against Epilepsy (ILAE) classification system organizes seizures based on where they originate in the brain and the level of awareness during the event.
| Category | Subcategory | Key Features | Clinical Significance |
|---|---|---|---|
| Focal Onset | Aware (simple partial) | Consciousness preserved; motor, sensory, autonomic, or psychic symptoms depending on cortical location | May serve as warning (aura) before generalization; localizing value for lesion |
| Impaired awareness (complex partial) | Altered consciousness; automatisms (lip smacking, picking at clothes); postictal confusion | Often temporal lobe origin; commonly mistaken for behavioral episodes | |
| Focal to bilateral tonic-clonic | Begins focally then spreads to both hemispheres; convulsive activity | Witness may only see generalized phase; focal onset suggests structural lesion | |
| Generalized Onset | Tonic-clonic (grand mal) | Loss of consciousness; tonic stiffening followed by clonic jerking; postictal confusion | Most recognized seizure type; high injury risk |
| Absence (petit mal) | Brief staring spells (5-30 seconds); abrupt onset and offset; no postictal confusion | Commonly misdiagnosed as inattention; typical in childhood | |
| Myoclonic | Brief, shock-like jerks of a muscle or muscle group; usually bilateral | May occur in clusters; often upon awakening; seen in juvenile myoclonic epilepsy | |
| Unknown Onset | Unwitnessed or unclear | Insufficient information to classify as focal or generalized | Reclassify when more information becomes available |
Classification by Etiology
Provoked (Acute Symptomatic) Seizures
Occur in close temporal relationship to an acute central nervous system insult or systemic condition. The seizure threshold is temporarily lowered by a reversible factor.
Common causes: Metabolic derangements (hypoglycemia, hyponatremia, hypocalcemia), drug intoxication or withdrawal, alcohol withdrawal, acute stroke, traumatic brain injury, central nervous system infections, fever (in children).
Clinical significance: Lower risk of recurrence once the provoking factor is corrected. Antiseizure medication may not be required long-term.
Unprovoked Seizures
Occur in the absence of an identifiable acute precipitant. May be the first presentation of epilepsy or result from a remote brain insult.
Categories: Idiopathic/genetic (no identifiable structural cause), structural (prior stroke, tumor, traumatic brain injury, cortical malformation), unknown cause.
Clinical significance: Higher risk of recurrence (approximately 40-50% after first unprovoked seizure). Requires consideration of long-term antiseizure medication.
Classification by Duration and Pattern
| Pattern | Duration | Clinical Features | Urgency |
|---|---|---|---|
| Self-limited seizure | Less than 5 minutes | Spontaneous termination; postictal period; full recovery | Urgent evaluation but not emergency if resolved |
| Prolonged seizure | 5 to 30 minutes | Requires pharmacological intervention to terminate | Emergency — administer benzodiazepine |
| Status epilepticus | Greater than 5 minutes continuous seizure activity OR 2 or more seizures without return to baseline | Risk of permanent neuronal injury; systemic complications; mortality 10-20% | Medical emergency — immediate intervention required |
| Cluster seizures | Multiple seizures within 24 hours with recovery between | Patient returns to baseline between events; may progress to status | Urgent — risk of progression |
Classification by Timing and Triggers
| Timing/Trigger | Description | Suggests |
|---|---|---|
| Sleep-related | Occurs primarily during sleep or upon awakening | Frontal lobe epilepsy; juvenile myoclonic epilepsy; benign rolandic epilepsy |
| Upon awakening | Within 2 hours of waking from sleep | Juvenile myoclonic epilepsy; idiopathic generalized epilepsy |
| Reflex seizures | Triggered by specific stimuli (flashing lights, reading, music) | Photosensitive epilepsy; reading epilepsy |
| Catamenial | Seizure clustering around menstruation | Hormonal influence on seizure threshold; consider hormonal adjunct therapy |
| Stress or sleep deprivation | Increased frequency with poor sleep, illness, or emotional stress | Common trigger in all epilepsy types; lifestyle modification important |
Key Concept: The Critical First Question
When evaluating a patient with a new seizure, the most important initial distinction is: Was this a seizure, or a seizure mimic? Up to 20-30% of patients referred to epilepsy centers are ultimately found to have psychogenic nonepileptic seizures (PNES) or other conditions mimicking seizures (syncope, transient ischemic attack, movement disorders). A detailed history from the patient AND a witness is essential.
Risk of Recurrence After First Unprovoked Seizure
Understanding Recurrence Risk
Overall risk of recurrence after a first unprovoked seizure is approximately 40-50% within 2 years. Factors that INCREASE recurrence risk include:
- Abnormal electroencephalogram (EEG): Epileptiform discharges double the recurrence risk
- Structural brain lesion: Prior stroke, tumor, traumatic brain injury, cortical dysplasia
- Nocturnal seizure: Seizure occurring during sleep
- Focal neurological deficit: Todd’s paralysis or other postictal deficits
- Family history of epilepsy
If recurrence risk exceeds 60%, the patient meets criteria for epilepsy diagnosis after a single seizure.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of seizures
Seizures result from an imbalance between excitatory and inhibitory neurotransmission in the brain, leading to abnormal, hypersynchronous neuronal firing. Understanding the underlying mechanisms helps explain why certain conditions provoke seizures and guides treatment selection. The brain normally maintains a delicate balance between excitation (primarily mediated by glutamate) and inhibition (primarily mediated by gamma-aminobutyric acid, or GABA). Any factor that tips this balance toward excessive excitation can lower the seizure threshold.
The Neuronal Basis of Seizures
| Component | Normal Function | Role in Seizure Generation |
|---|---|---|
| Excitatory neurotransmission (Glutamate) | Primary excitatory neurotransmitter; activates NMDA and AMPA receptors; allows sodium and calcium influx | Excessive glutamate release or receptor hypersensitivity leads to neuronal hyperexcitability |
| Inhibitory neurotransmission (GABA) | Primary inhibitory neurotransmitter; opens chloride channels; hyperpolarizes neurons | Reduced GABA synthesis, release, or receptor function decreases inhibitory tone |
| Voltage-gated ion channels | Sodium, potassium, and calcium channels regulate neuronal excitability and action potential propagation | Channelopathies (genetic or acquired dysfunction) alter neuronal firing patterns |
| Astrocytes and glia | Regulate extracellular ion concentrations; clear excess glutamate; maintain blood-brain barrier | Glial dysfunction impairs ion homeostasis and neurotransmitter clearance |
| Cortical interneurons | Provide feedback and feedforward inhibition; synchronize cortical activity | Loss of interneuron function (as in certain genetic epilepsies) leads to hypersynchrony |
Ion Channel Mechanisms and Drug Targets
Sodium Channels
Normal function: Rapid depolarization during action potential; inactivate quickly to allow repolarization
In seizures: Persistent sodium channel activation leads to repetitive firing
Drug targets: Phenytoin, carbamazepine, lamotrigine, lacosamide block sodium channels in their inactivated state
Calcium Channels
Normal function: T-type calcium channels generate low-threshold spikes in thalamic neurons; important for sleep rhythms
In seizures: Abnormal T-type channel activity underlies the 3 Hz spike-wave pattern of absence seizures
Drug targets: Ethosuximide blocks T-type calcium channels; first-line for absence seizures
GABA Receptors
Normal function: GABA-A receptors open chloride channels, hyperpolarizing neurons and reducing excitability
In seizures: Reduced GABA-ergic inhibition removes the “brake” on neuronal firing
Drug targets: Benzodiazepines and barbiturates enhance GABA-A receptor activity; valproate increases GABA synthesis
Phases of a Generalized Tonic-Clonic Seizure
| Phase | Duration | Clinical Features | Underlying Mechanism |
|---|---|---|---|
| Prodrome (optional) | Hours to days before | Mood changes, irritability, headache — not present in all patients | Unclear; possibly related to building cortical excitability |
| Aura (if focal onset) | Seconds to minutes | Subjective warning symptoms: rising epigastric sensation, déjà vu, fear, visual or olfactory hallucinations | Focal seizure activity in eloquent cortex before secondary generalization |
| Tonic phase | 10-20 seconds | Sudden loss of consciousness; generalized stiffening; “epileptic cry” (forced expiration through closed glottis); falls; may bite tongue | Massive synchronous depolarization of cortical neurons; sustained muscle contraction |
| Clonic phase | 30-60 seconds | Rhythmic jerking of all extremities; frequency decreases as phase progresses; drooling; cyanosis | Alternating excitation and inhibition; gradual GABA-mediated dampening |
| Postictal phase | Minutes to hours | Confusion, fatigue, headache, muscle soreness; may have transient focal deficits (Todd’s paralysis) | Neuronal exhaustion; active inhibition; metabolic recovery; cerebral edema in some cases |
How Clinical Conditions Lower the Seizure Threshold
| Condition | Mechanism | Clinical Implication |
|---|---|---|
| Hypoglycemia | Glucose is the brain’s primary energy substrate; deprivation impairs the sodium-potassium ATPase pump, leading to membrane instability | Always check glucose immediately; seizure resolves with glucose correction |
| Hyponatremia | Decreased extracellular sodium reduces the threshold for action potential generation; cerebral edema in severe cases | Rapid correction can cause osmotic demyelination; correct sodium slowly unless actively seizing |
| Hypocalcemia | Low extracellular calcium increases neuronal membrane excitability by altering voltage-gated channel behavior | Look for other signs: tetany, Chvostek sign, prolonged QT interval |
| Alcohol withdrawal | Chronic alcohol upregulates NMDA glutamate receptors and downregulates GABA receptors; removal of alcohol leads to unopposed excitation | Seizures typically occur 6-48 hours after last drink; peak risk of delirium tremens at 48-72 hours |
| Benzodiazepine or barbiturate withdrawal | Similar to alcohol: chronic use downregulates GABA receptors; abrupt cessation removes inhibitory tone | Potentially life-threatening; requires supervised taper |
| Drug intoxication (stimulants, tramadol, bupropion) | Stimulants increase catecholamines and glutamate; some drugs lower seizure threshold by blocking sodium channels or GABA | Obtain urine drug screen; specific antidotes may be available |
| Acute stroke | Ischemia releases glutamate; ion pump failure leads to cytotoxic edema; cortical irritation from hemorrhage | Early seizures (within 7 days) are provoked; late seizures suggest post-stroke epilepsy |
| Traumatic brain injury | Direct neuronal damage; hemorrhage; inflammation; scarring (gliosis) creates epileptogenic focus | Early post-traumatic seizures (within 7 days) differ from late (post-traumatic epilepsy) |
| Central nervous system infection | Inflammation; direct neuronal invasion; fever; metabolic derangements; blood-brain barrier disruption | Herpes simplex encephalitis has predilection for temporal lobes; high seizure risk |
| Brain tumor | Mass effect; disruption of normal cortical architecture; peritumoral edema; metabolic changes | Seizures may be presenting symptom; low-grade tumors often more epileptogenic than high-grade |
| Eclampsia | Endothelial dysfunction; vasospasm; posterior reversible encephalopathy syndrome (PRES) | Magnesium sulfate is treatment of choice (blocks NMDA receptors) |
Genetic Mechanisms in Epilepsy
Channelopathies
Mutations in genes encoding ion channels are the most common identified cause of genetic epilepsy. Examples include:
- SCN1A mutations: Sodium channel dysfunction; Dravet syndrome; severe myoclonic epilepsy of infancy
- KCNQ2/3 mutations: Potassium channel dysfunction; benign familial neonatal seizures
- CACNA1A mutations: Calcium channel dysfunction; associated with absence epilepsy and episodic ataxia
Idiopathic Generalized Epilepsies
Polygenic inheritance with complex genetics. The brain is structurally normal, but there is an inherited predisposition to seizures. Examples include:
- Childhood absence epilepsy: Peak onset age 4-8 years; typical 3 Hz spike-wave on EEG
- Juvenile myoclonic epilepsy: Onset in adolescence; myoclonic jerks upon awakening; lifelong treatment usually required
- Juvenile absence epilepsy: Later onset than childhood form; higher risk of generalized tonic-clonic seizures
Often Overlooked Mechanism: The Role of Sleep Deprivation
Sleep deprivation is one of the most potent and underappreciated seizure triggers. During sleep, the brain undergoes restorative processes that maintain the excitation-inhibition balance. Sleep deprivation leads to:
- Increased cortical excitability (demonstrated by transcranial magnetic stimulation studies)
- Impaired GABA-mediated inhibition
- Increased interictal epileptiform discharges on EEG
Clinical tip: Always ask about sleep patterns in patients with new or breakthrough seizures. In juvenile myoclonic epilepsy, sleep deprivation alone can precipitate seizures in otherwise well-controlled patients.
Pathophysiology of Status Epilepticus: Time-Dependent Changes
Why Prolonged Seizures Are Dangerous
As seizures continue, several time-dependent pathophysiological changes occur that make termination progressively more difficult:
- 0-5 minutes: GABA-A receptors internalize (move from membrane into cell), reducing benzodiazepine efficacy
- 5-30 minutes: NMDA glutamate receptors traffic to the cell surface, increasing excitatory tone
- 30+ minutes: Excitotoxic neuronal injury begins; systemic complications develop (hyperthermia, acidosis, rhabdomyolysis)
Clinical implication: Early benzodiazepine administration (within 5 minutes) is critical. Delayed treatment reduces benzodiazepine effectiveness and increases the need for second-line agents.
3. History Taking
A comprehensive approach to eliciting the seizure history
Red Flags — Require Urgent Evaluation
- Prolonged seizure (greater than 5 minutes) — Status epilepticus; immediate intervention required
- Multiple seizures without recovery — Impending or established status epilepticus
- Fever with seizure in adult — Central nervous system infection (meningitis, encephalitis)
- New focal neurological deficit — Stroke, mass lesion, Todd’s paralysis
- Severe headache before or after seizure — Subarachnoid hemorrhage, intracranial hemorrhage, venous sinus thrombosis
- Seizure following head trauma — Intracranial hemorrhage, traumatic brain injury
- First seizure in pregnancy or postpartum — Eclampsia, cerebral venous thrombosis, posterior reversible encephalopathy syndrome
- Immunocompromised patient — Opportunistic central nervous system infection, lymphoma
- Known malignancy — Brain metastases, paraneoplastic syndrome, metabolic complications
- Anticoagulation use — Intracranial hemorrhage risk
The history is the cornerstone of seizure evaluation. Since most patients do not seize in front of a clinician, diagnosis relies heavily on a detailed account from both the patient AND any witnesses. The goals are to: (1) confirm whether the event was truly a seizure, (2) classify the seizure type, (3) identify potential causes or triggers, and (4) assess the risk of recurrence.
Systematic History: The “SEIZE” Approach
Use the mnemonic “SEIZE” to ensure comprehensive history taking for a new seizure:
- S — Setting and Start: Where were they? What were they doing? Was there any warning (aura)? How did it begin — suddenly or gradually? Was onset witnessed?
- E — Event Description: What exactly happened? Body movements (stiffening, jerking, one side versus both)? Eyes (open, deviated, rolled back)? Sounds (cry, grunting)? Color change? Incontinence? Tongue biting?
- I — Ictal Duration and Interval: How long did it last? (Witnesses often overestimate) Was there more than one event? Time between events? Did they return to normal between episodes?
- Z — Zone of Recovery (Postictal): What happened afterward? Confusion (how long)? Sleepiness? Headache? Weakness on one side? Able to speak normally? Memory of the event?
- E — Etiology Clues: Any provoking factors? Recent illness, sleep deprivation, alcohol or drug use, medication changes, missed doses? Prior seizures or neurological history? Family history of seizures?
Key Questions: Seizure Versus Seizure Mimics
Up to 20-30% of patients referred for “seizures” have an alternative diagnosis. The following features help distinguish true seizures from common mimics:
| Feature | True Seizure | Syncope | Psychogenic Nonepileptic Seizure |
|---|---|---|---|
| Trigger or warning | Aura (rising sensation, déjà vu, fear); may occur without warning | Prodrome: lightheadedness, warmth, tunnel vision, nausea; often positional | Often emotional trigger; may occur in presence of others |
| Duration | Usually 30 seconds to 2 minutes | Brief (less than 30 seconds of unconsciousness) | Often prolonged (many minutes to hours); waxing and waning |
| Motor activity | Tonic-clonic: rhythmic, synchronous; frequency decreases over time | Brief myoclonic jerks possible (convulsive syncope); arrhythmic | Asynchronous; side-to-side head movement; pelvic thrusting; eyes closed |
| Eyes during event | Open; may be deviated to one side | Open or closed; eyes may roll up briefly | Often tightly closed; resist passive opening |
| Tongue biting | Lateral tongue biting highly specific for seizure | Tip of tongue bite may occur | Rare; if present, usually tip of tongue |
| Incontinence | Common (urinary more than fecal) | May occur | Less common; may occur |
| Postictal state | Prolonged confusion (minutes to hours); sleepiness; headache; muscle soreness | Rapid recovery (seconds to minutes); may feel nauseated or tired | Variable; may be alert immediately or appear unresponsive; often rapid fluctuation |
| Recall of event | No memory of ictal period; may recall aura | May recall prodrome; amnesia for period of unconsciousness | Variable; some patients describe awareness during event |
| Injury | Common (falls, burns, tongue laceration) | May occur from fall | Less common; self-protective movements often preserved |
Clinical Pearl: Lateral Tongue Biting
Lateral tongue biting (on the side of the tongue) is highly specific for generalized tonic-clonic seizures and is one of the most reliable features distinguishing true seizures from syncope or psychogenic events. Ask specifically: “Did you bite your tongue? Can you show me where?” The sensitivity is low (approximately 20-30%), but specificity exceeds 95%.
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Alcohol withdrawal | Seizure 6-48 hours after last drink; tremor; autonomic instability | “When was your last alcoholic drink? How much do you typically drink per day? Have you had withdrawal seizures before?” |
| Hypoglycemia | Diabetic patient; missed meal; excess insulin; adrenergic symptoms before seizure | “Are you diabetic? Did you take your insulin? When did you last eat? Did you feel shaky or sweaty beforehand?” |
| Drug intoxication or toxicity | Recent overdose; stimulant use; medication changes; suicidal ideation | “Have you taken any recreational drugs? Started any new medications? Taken more than prescribed of any medication?” |
| Medication withdrawal | Recent discontinuation of benzodiazepines, barbiturates, or antiseizure medications | “Have you stopped or missed any medications recently? Any sleeping pills or anxiety medications?” |
| Central nervous system infection | Fever; headache; neck stiffness; altered mental status; rash | “Have you had fever? Severe headache? Stiff neck? Confusion before the seizure? Any recent travel or sick contacts?” |
| Stroke | Sudden focal deficits; vascular risk factors; older patient | “Did you notice any weakness, numbness, or speech problems before or after? Do you have high blood pressure, diabetes, or heart problems?” |
| Brain tumor | Progressive headaches; focal deficits; personality change; weight loss | “Have you had worsening headaches? Any weakness or numbness? Changes in vision, personality, or memory? Unintentional weight loss?” |
| Eclampsia | Pregnant or recently postpartum; hypertension; edema; visual changes | “Are you pregnant or have you recently delivered? Have you had headaches, swelling, or vision changes? Do you know your blood pressure?” |
| Sleep deprivation | Inadequate sleep; shift work; new parent; examinations | “How much sleep have you been getting? Have you been staying up late or working night shifts? Any recent changes in sleep pattern?” |
| Idiopathic generalized epilepsy | Adolescent or young adult; seizures upon awakening; myoclonic jerks; family history | “Do you ever have sudden jerking movements, especially in the morning? Does anyone in your family have seizures or epilepsy?” |
| Temporal lobe epilepsy | Aura (rising sensation, déjà vu, fear); automatisms; history of febrile seizures | “Do you get a warning before seizures — like a strange feeling in your stomach, or a feeling you’ve experienced this before? Did you have seizures with fevers as a child?” |
Essential Witness Questions
The witness history is often more valuable than the patient history. If a witness is available (in person or by phone), ask these specific questions:
- “What was the patient doing immediately before the event?”
- “Did they say anything or make any sound at the start?”
- “What did their body do? Did they stiffen, then shake? One side or both sides?”
- “What did their eyes do? Were they open? Looking to one side?”
- “Did they change color — pale, blue, or flushed?”
- “How long did it last?” (Ask them to demonstrate with a clock if possible — witnesses commonly overestimate)
- “What happened when it stopped? How long until they were back to normal?”
- “Have you ever seen them do this before?”
Medication and Substance History
Medications That Can CAUSE Seizures
- Antidepressants: Bupropion (dose-dependent), tricyclic antidepressants (in overdose), venlafaxine
- Antipsychotics: Clozapine (highest risk), chlorpromazine, olanzapine
- Analgesics: Tramadol, meperidine (normeperidine metabolite)
- Antibiotics: Carbapenems (imipenem highest risk), fluoroquinolones, isoniazid (pyridoxine deficiency)
- Immunosuppressants: Cyclosporine, tacrolimus (posterior reversible encephalopathy syndrome)
- Stimulants: Cocaine, amphetamines, synthetic cathinones
- Others: Theophylline, lithium (toxicity), baclofen withdrawal
Substances and Withdrawal States
- Alcohol withdrawal: Peak risk 6-48 hours after cessation; especially if heavy, prolonged use
- Benzodiazepine withdrawal: Can occur even with prescribed use; potentially life-threatening
- Barbiturate withdrawal: Similar to alcohol; severe withdrawal syndrome
- Gamma-hydroxybutyrate (GHB) withdrawal: Increasingly recognized; severe autonomic instability
- Stimulant intoxication: Cocaine, methamphetamine, synthetic cathinones
- Synthetic cannabinoids: Unpredictable effects; seizures reported
- Opioid withdrawal: Seizures are rare in pure opioid withdrawal but may occur with mixed substances
Past Medical and Family History
Relevant Past Medical History
- Previous seizures or epilepsy diagnosis
- Head trauma (even remote — years prior)
- Stroke or transient ischemic attack
- Brain surgery or brain tumor
- Meningitis or encephalitis
- Febrile seizures in childhood
- Developmental delay or intellectual disability
- Psychiatric history (increased PNES risk)
- Diabetes mellitus (hypoglycemia risk)
- Chronic kidney disease (uremia, electrolyte disturbances)
- Liver disease (hepatic encephalopathy, coagulopathy)
- HIV or immunocompromised state
- Malignancy (metastases, paraneoplastic syndromes)
Family History
Family history is particularly relevant in patients presenting with a first seizure in adolescence or young adulthood:
- Epilepsy or seizure disorder
- Febrile seizures
- Sudden unexplained death (possible SUDEP in undiagnosed epilepsy)
- Neurological disorders (neurodegenerative diseases, tuberous sclerosis, neurofibromatosis)
- Psychiatric disorders (may suggest PNES)
Note: A positive family history of epilepsy increases recurrence risk after a first unprovoked seizure and may support the diagnosis of an idiopathic generalized epilepsy syndrome.
Social and Occupational History
Why Social History Matters in Seizure
Social history identifies both potential causes and important safety considerations for counseling:
- Alcohol use: Quantify intake (CAGE questionnaire); assess withdrawal risk; heavy use is both a trigger and complicates management
- Recreational drug use: Cocaine, amphetamines, synthetic drugs; urine drug screen indicated
- Sleep patterns: Shift work, new parent, student with irregular schedule — sleep deprivation is a major trigger
- Occupation: Driving, operating heavy machinery, working at heights, healthcare worker — affects counseling about activity restrictions
- Living situation: Lives alone versus with others (safety monitoring); access to bathtub (drowning risk)
- Pregnancy status: Affects imaging, medication choices, and urgency of evaluation
4. Physical Examination
A systematic head-to-toe approach for patients presenting with seizure
Examination Goals: The physical examination in a patient with new seizure aims to: (1) identify evidence that a seizure occurred (tongue bite, injury), (2) detect signs of an underlying cause (infection, metabolic derangement, structural lesion), (3) assess current neurological status (postictal state, focal deficits), and (4) identify conditions that may mimic seizure (cardiac disease, hypoglycemia).
General Inspection
- Level of consciousness: Alert, confused, drowsy, obtunded — postictal confusion typically resolves within 30-60 minutes; prolonged confusion suggests status epilepticus, nonconvulsive seizures, or underlying brain pathology
- Respiratory pattern: Tachypnea (metabolic acidosis from prolonged seizure), Cheyne-Stokes (bilateral hemispheric or brainstem dysfunction), agonal breathing (ongoing seizure or severe brain injury)
- Signs of injury: Bruises, lacerations, shoulder dislocation (posterior dislocation classic for seizure), scalp hematoma, facial trauma
- Incontinence: Wet clothing, urine odor — supports diagnosis of generalized seizure but not specific
- Signs of substance use: Track marks, alcohol on breath, dilated or constricted pupils, diaphoresis
- Medic alert jewelry: Check for epilepsy, diabetes, or other relevant conditions
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C / 100.4°F); hypothermia | Fever: central nervous system infection, sepsis, prolonged seizure-induced hyperthermia. Hypothermia: environmental exposure, hypothyroidism, sepsis |
| Heart Rate | Tachycardia; bradycardia; irregular rhythm | Tachycardia: postictal, fever, substance use, withdrawal. Bradycardia: increased intracranial pressure, cardiac arrhythmia as seizure mimic. Irregular: atrial fibrillation (stroke risk) |
| Blood Pressure | Hypertension; hypotension | Severe hypertension: eclampsia, posterior reversible encephalopathy syndrome, hypertensive encephalopathy, autonomic instability in withdrawal. Hypotension: sepsis, postictal, cardiac cause |
| Respiratory Rate | Tachypnea; bradypnea; apnea | Tachypnea: compensation for lactic acidosis after prolonged seizure. Bradypnea/apnea: ongoing nonconvulsive seizure, medication effect, increased intracranial pressure |
| Oxygen Saturation | Hypoxia (less than 94%) | May persist postictally; consider aspiration, ongoing subtle seizure, pulmonary edema (neurogenic or cardiac) |
| Blood Glucose | Hypoglycemia (less than 70 mg/dL); hyperglycemia | Hypoglycemia is immediately treatable cause of seizure. Hyperglycemia: diabetic ketoacidosis, hyperosmolar state (nonketotic hyperglycemia can cause focal seizures) |
Check Glucose Immediately
Point-of-care glucose should be checked in ALL patients presenting with seizure or altered mental status. Hypoglycemia is a rapidly reversible cause of seizures, and delayed recognition can lead to permanent neurological injury. Do not wait for laboratory results — use bedside glucometer.
Head and Neck Examination
Head
- Scalp: Lacerations, hematomas, signs of trauma — may indicate fall during seizure or raise concern for traumatic cause
- Battle sign: Mastoid ecchymosis — basilar skull fracture
- Raccoon eyes: Periorbital ecchymosis — basilar skull fracture
- Hemotympanum: Blood behind tympanic membrane — basilar skull fracture
- CSF rhinorrhea or otorrhea: Clear fluid from nose or ear — skull fracture with dural tear
Neck
- Meningismus: Nuchal rigidity, Kernig sign, Brudzinski sign — meningitis, subarachnoid hemorrhage (evaluate carefully; protect cervical spine if trauma suspected)
- Thyroid: Goiter, thyroidectomy scar — hypocalcemia from hypoparathyroidism, thyroid storm
- Lymphadenopathy: May suggest infection, malignancy
- Carotid bruits: Cerebrovascular disease, stroke risk
- Jugular venous distension: Right heart failure, superior vena cava syndrome (mass)
Oral Examination
Examine the Tongue Carefully
The location of tongue injury is diagnostically important:
- Lateral tongue laceration: Highly specific for generalized tonic-clonic seizure (tongue caught between molars during tonic phase)
- Tip of tongue bite: Nonspecific — may occur in syncope, psychogenic events, or seizures
- Buccal mucosa lacerations: Also support seizure diagnosis
Also examine for: gingival hyperplasia (chronic phenytoin use in known epilepsy), poor dentition, and oral candidiasis (immunocompromised state).
Neurological Examination
A thorough neurological examination is essential to identify focal deficits suggesting a structural lesion and to monitor recovery from the postictal state.
Mental Status
- Level of consciousness: Glasgow Coma Scale if decreased; assess orientation to person, place, time, and situation
- Attention: Digit span, serial 7s, spelling “WORLD” backward — impaired attention common postictally
- Language: Spontaneous speech, naming, repetition, comprehension — dysphasia suggests dominant hemisphere involvement
- Memory: Short-term recall — impaired postictally; persistent deficit suggests structural lesion or ongoing nonconvulsive seizures
Cranial Nerves
| Cranial Nerve(s) | What to Assess | Abnormality Suggests |
|---|---|---|
| II (Optic) | Visual acuity, visual fields, pupillary response, fundoscopy | Papilledema: increased intracranial pressure. Visual field cut: occipital or parietal lesion. Pupil abnormalities: herniation, drug effect |
| III, IV, VI (Oculomotor, Trochlear, Abducens) | Eye movements, conjugate gaze, nystagmus | Gaze deviation: toward lesion (hemispheric stroke) or away from lesion (seizure focus). Sixth nerve palsy: increased intracranial pressure (false localizing sign) |
| VII (Facial) | Facial symmetry at rest and with movement | Unilateral weakness: stroke, mass lesion. Lower motor neuron pattern (forehead involved): peripheral lesion |
| IX, X (Glossopharyngeal, Vagus) | Palate elevation, gag reflex, voice quality | Asymmetry: brainstem lesion. Absent gag: aspiration risk |
| XII (Hypoglossal) | Tongue protrusion, tongue atrophy, fasciculations | Deviation toward weak side: contralateral hemisphere lesion |
Motor Examination
- Tone: Increased (spasticity from prior stroke or ongoing seizure activity) or decreased (postictal, medication effect)
- Strength: Test all major muscle groups; look for hemiparesis or monoparesis
- Todd’s paralysis: Focal weakness following a seizure, typically resolving within 24-48 hours; suggests focal seizure origin and lateralizes to the side of the seizure focus
- Pronator drift: Sensitive test for subtle hemiparesis — arms extended, palms up, eyes closed
- Asterixis: “Flapping tremor” — metabolic encephalopathy (hepatic, uremic)
Reflexes
- Deep tendon reflexes: Asymmetry suggests upper motor neuron lesion; hyperreflexia on one side supports focal pathology
- Plantar response: Extensor (Babinski sign) indicates upper motor neuron dysfunction; may be present postictally but should resolve
- Clonus: Sustained rhythmic contractions with sustained stretch — upper motor neuron lesion
Sensory and Coordination
- Sensory: Test light touch, pinprick, vibration, proprioception — hemisensory loss suggests thalamic or cortical lesion
- Coordination: Finger-nose-finger, heel-knee-shin, rapid alternating movements — cerebellar dysfunction (phenytoin toxicity, posterior fossa lesion)
- Gait: If patient can safely ambulate — assess for hemiparesis, ataxia, apraxia
Cardiovascular Examination
Important to identify cardiac causes of syncope that may mimic seizure (convulsive syncope):
- Heart sounds: Murmurs (aortic stenosis — syncope with exertion), irregular rhythm
- Carotid pulses: Asymmetry, bruits — cerebrovascular disease
- Peripheral pulses: Quality, symmetry
- Edema: Peripheral edema — heart failure, nephrotic syndrome (uremic encephalopathy)
- Orthostatic vital signs: If syncope is in the differential — drop in systolic blood pressure greater than 20 mmHg or diastolic greater than 10 mmHg upon standing
Skin Examination
| Finding | Description | Associated Condition |
|---|---|---|
| Petechial or purpuric rash | Non-blanching lesions, especially with fever | Meningococcemia — medical emergency |
| Ash-leaf spots | Hypopigmented macules (best seen with Wood’s lamp) | Tuberous sclerosis — associated with epilepsy |
| Café-au-lait spots | Flat, hyperpigmented macules | Neurofibromatosis type 1 — brain tumors, seizures |
| Facial angiofibromas | Red papules on face in butterfly distribution | Tuberous sclerosis |
| Port-wine stain (facial) | Capillary malformation in trigeminal distribution | Sturge-Weber syndrome — cortical venous malformation, seizures |
| Track marks | Injection sites on arms, between toes | Intravenous drug use — consider intoxication, infection, endocarditis |
| Jaundice | Yellow discoloration of skin and sclera | Hepatic encephalopathy — asterixis, altered mental status |
| Spider angiomata, palmar erythema | Signs of chronic liver disease | Hepatic encephalopathy, alcohol-related complications |
Expected Findings by Etiology
| Condition | General/Vital Signs | Neurological | Other Key Findings |
|---|---|---|---|
| Meningitis/Encephalitis | Fever, tachycardia | Nuchal rigidity, altered mental status, photophobia | Petechial rash (meningococcus), herpetic vesicles (HSV) |
| Acute stroke | Hypertension, atrial fibrillation | Focal deficits (hemiparesis, aphasia, visual field cut), gaze deviation | Carotid bruit, cardiac murmur |
| Brain tumor | Often normal vitals | Papilledema, focal deficits, personality changes | Weight loss, lymphadenopathy if metastatic |
| Alcohol withdrawal | Tachycardia, hypertension, fever, diaphoresis | Tremor, agitation, hallucinations (in severe cases) | Signs of chronic liver disease, poor nutrition |
| Hypoglycemia | Tachycardia, diaphoresis | Confusion, focal deficits possible, rapid improvement with glucose | Insulin injection sites, diabetic identification |
| Uremia | Hypertension, Kussmaul breathing | Asterixis, myoclonus, encephalopathy | Pallor, uremic frost (severe), edema |
| Eclampsia | Severe hypertension, edema | Hyperreflexia, clonus, altered mental status | Pregnant or recently postpartum, proteinuria |
| Drug intoxication | Variable — tachycardia, hyperthermia with stimulants | Dilated pupils (stimulants), miosis (opioids), agitation or obtundation | Track marks, pill bottles, drug paraphernalia |
| Idiopathic generalized epilepsy | Normal | Normal (except during postictal period) | No abnormalities; diagnosis based on history and EEG |
Important Teaching Point
Normal examination is common in first seizure! Many patients with a first unprovoked seizure — especially those with idiopathic generalized epilepsy, juvenile myoclonic epilepsy, or temporal lobe epilepsy — will have completely normal physical and neurological examinations once the postictal period has resolved. A normal examination does not exclude epilepsy or the need for further workup. The examination primarily helps identify acute symptomatic causes (infection, metabolic derangement, stroke) and neurocutaneous syndromes, and monitors for persistent focal deficits that would suggest a structural lesion requiring urgent imaging.
The Importance of Serial Examination
Re-examine as the postictal state resolves. Many findings in the immediate postictal period (confusion, lethargy, transient focal weakness) will improve over minutes to hours. Serial examinations help to:
- Document resolution of postictal confusion (typical: 30-60 minutes; prolonged suggests ongoing seizures or structural pathology)
- Distinguish Todd’s paralysis (should improve within 24-48 hours) from stroke (deficits persist)
- Identify nonconvulsive status epilepticus if patient fails to improve as expected
- Monitor for seizure recurrence
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
When evaluating a patient with a new convulsion or suspected seizure, the differential diagnosis must address two fundamental questions: (1) Was this truly a seizure, or a seizure mimic? and (2) If it was a seizure, what caused it? The approach differs for provoked (acute symptomatic) seizures versus unprovoked seizures, as the underlying causes and management differ substantially.
Step-by-Step Approach to the New Seizure:
- Step 1: Confirm this was a seizure — Rule out syncope, psychogenic nonepileptic seizures, and other mimics
- Step 2: Identify provoked causes — Check glucose, electrolytes, toxicology; assess for acute brain injury, infection, withdrawal
- Step 3: If unprovoked — Classify seizure type (focal versus generalized) and investigate for structural cause or epilepsy syndrome
- Step 4: Risk stratify — Determine recurrence risk and need for antiseizure medication
Seizure Mimics — “Was This Really a Seizure?”
Up to 20-30% of patients referred for presumed seizures have an alternative diagnosis. Always consider mimics before attributing an episode to seizure.
| Condition | Key Distinguishing Features | Helpful Investigations |
|---|---|---|
| Syncope (including convulsive syncope) | Prodrome (lightheadedness, warmth, tunnel vision); brief loss of consciousness (less than 30 seconds); rapid recovery; may have brief myoclonic jerks; triggered by standing, heat, pain, micturition | ECG, orthostatic vital signs, echocardiogram, tilt table testing if recurrent |
| Psychogenic nonepileptic seizures (PNES) | Eyes often closed; asynchronous movements; side-to-side head movement; pelvic thrusting; prolonged duration; waxing and waning; preserved awareness during apparent “convulsion”; rapid return to baseline; often in presence of others; psychiatric comorbidity | Video-EEG monitoring (gold standard); normal ictal EEG during event; prolactin not elevated |
| Transient ischemic attack | Negative symptoms (weakness, numbness, visual loss) rather than positive symptoms; no loss of consciousness; duration minutes to hours; vascular risk factors | MRI brain with diffusion-weighted imaging, CT/MR angiography, carotid ultrasound, ECG |
| Transient global amnesia | Sudden onset anterograde amnesia; repetitive questioning; no loss of consciousness; resolves within 24 hours; no focal deficits | MRI (may show hippocampal diffusion restriction); clinical diagnosis |
| Movement disorders (dystonia, tics, myoclonus) | No alteration of consciousness; stereotyped movements; may be suppressible; no postictal state | Clinical observation; video documentation; neurology referral |
| Migraine with aura | Visual, sensory, or motor symptoms spreading over minutes (not seconds); headache follows; personal or family history of migraine | Clinical diagnosis; MRI brain if atypical features |
| Panic attack | Intense fear; palpitations; hyperventilation; paresthesias; sense of impending doom; no loss of consciousness; often situational trigger | Clinical diagnosis; rule out cardiac and metabolic causes |
| Hypoglycemia (without seizure) | Diaphoresis, tremor, confusion, behavioral changes; relieved with glucose; diabetic patient | Point-of-care glucose during episode |
| Sleep disorders (narcolepsy, parasomnias) | Cataplexy triggered by emotion; complex behaviors from sleep; no postictal confusion; occurs from sleep | Polysomnography, multiple sleep latency test |
Provoked (Acute Symptomatic) Seizures
Provoked seizures occur in close temporal relationship to an acute systemic or central nervous system insult. Identifying and treating the underlying cause is the priority; long-term antiseizure medication is usually not required.
| Probability | Cause | Key Clinical Features | Immediate Action |
|---|---|---|---|
| COMMON | Alcohol withdrawal | Seizure 6-48 hours after last drink; history of heavy alcohol use; tremor, diaphoresis, tachycardia, hypertension | Benzodiazepines; CIWA protocol; thiamine; monitor for delirium tremens |
| COMMON | Hypoglycemia | Diabetic patient; insulin or sulfonylurea use; missed meal; glucose less than 50-60 mg/dL | IV dextrose or oral glucose; identify cause of hypoglycemia |
| COMMON | Drug intoxication | Stimulants (cocaine, amphetamines), tramadol, bupropion, isoniazid, theophylline; toxidrome signs | Supportive care; specific antidotes if available (pyridoxine for isoniazid) |
| COMMON | Medication non-adherence (known epilepsy) | Subtherapeutic antiseizure medication levels; patient admits missing doses | Reload antiseizure medication; address barriers to adherence |
| LESS COMMON | Hyponatremia | Sodium typically less than 120 mEq/L; acute (less than 48 hours) or chronic; causes include SIADH, diuretics, polydipsia | Hypertonic saline if seizing; avoid rapid correction (osmotic demyelination risk) |
| LESS COMMON | Acute stroke (ischemic or hemorrhagic) | Focal neurological deficits; seizure at stroke onset or within 7 days; risk factors for cerebrovascular disease | CT head; stroke protocol; short-term antiseizure medication if recurrent early seizures |
| LESS COMMON | Traumatic brain injury | Early post-traumatic seizure (within 7 days of injury); scalp laceration, bruising; amnesia for event | CT head; seizure prophylaxis for 7 days in severe TBI |
| LESS COMMON | Central nervous system infection | Meningitis: fever, headache, neck stiffness, altered mental status. Encephalitis: more prominent confusion, focal signs, behavioral changes | Lumbar puncture (if safe); empiric antibiotics and acyclovir; urgent imaging |
| LESS COMMON | Benzodiazepine or barbiturate withdrawal | Recent cessation of chronic use; anxiety, tremor, autonomic instability; potentially life-threatening | Reinstate benzodiazepine; supervised taper |
| UNCOMMON BUT SERIOUS | Eclampsia | Pregnant (especially third trimester) or postpartum; hypertension, edema, proteinuria; visual changes, headache | Magnesium sulfate; antihypertensives; urgent obstetric consultation; delivery if severe |
| UNCOMMON BUT SERIOUS | Hypocalcemia | Post-thyroidectomy; chronic kidney disease; vitamin D deficiency; tetany, Chvostek sign, prolonged QT | IV calcium gluconate; cardiac monitoring |
| UNCOMMON BUT SERIOUS | Uremia | Advanced chronic kidney disease; asterixis, myoclonus, encephalopathy; very elevated BUN/creatinine | Urgent dialysis consideration |
| UNCOMMON BUT SERIOUS | Posterior reversible encephalopathy syndrome (PRES) | Severe hypertension; immunosuppressive drugs; headache, visual changes, altered mental status; MRI shows posterior white matter edema | Blood pressure control; remove offending agent; supportive care |
Unprovoked Seizures — Epilepsy and Structural Causes
If no acute provocation is identified, the seizure is classified as unprovoked. This may represent the first manifestation of epilepsy (genetic or structural) or a remote symptomatic seizure (due to prior brain injury).
| Probability | Condition | Typical Presentation | Key Diagnostic Features |
|---|---|---|---|
| COMMON (approximately 30-40%) | Unknown cause (cryptogenic) | Normal examination; no identifiable structural lesion or genetic cause; often diagnosed as epilepsy if recurrent | Normal MRI; may have epileptiform abnormalities on EEG |
| COMMON (approximately 20-30%) | Idiopathic generalized epilepsy | Adolescent or young adult; normal neurological examination; may have myoclonic jerks upon awakening; family history | Generalized spike-wave on EEG; normal MRI; genetic predisposition |
| LESS COMMON (approximately 10-20%) | Remote symptomatic (prior stroke, traumatic brain injury, encephalitis) | History of prior brain injury (months to years ago); focal seizure type; may have residual deficits | MRI shows encephalomalacia, gliosis, or atrophy corresponding to prior injury |
| LESS COMMON (approximately 10-15%) | Mesial temporal sclerosis | History of febrile seizures in childhood; focal seizures with impaired awareness; aura (rising epigastric sensation, déjà vu); automatisms | MRI shows hippocampal atrophy and signal change; temporal spikes on EEG |
| LESS COMMON | Brain tumor (primary or metastatic) | Progressive headaches; focal deficits; personality change; known primary cancer; age-dependent (glioma in younger, metastases in older) | MRI with contrast; low-grade tumors often more epileptogenic than high-grade |
| LESS COMMON | Vascular malformation (arteriovenous malformation, cavernoma) | Often young adult; may present with seizure, hemorrhage, or incidentally discovered; seizures may be focal | MRI (cavernoma: “popcorn” lesion; AVM: flow voids); may require angiography |
| UNCOMMON | Cortical dysplasia | Childhood or young adult onset; often drug-resistant focal epilepsy; may be subtle on imaging | High-resolution MRI may show focal cortical thickening, blurring of gray-white junction |
| UNCOMMON | Autoimmune encephalitis | Subacute onset of seizures, psychiatric symptoms, memory problems; may have preceding viral illness or tumor (paraneoplastic) | CSF pleocytosis; autoimmune antibody panel (anti-NMDA receptor, anti-LGI1, anti-CASPR2, etc.); MRI may show mesial temporal signal change |
| UNCOMMON | Neurodegenerative disease | Older adult; cognitive decline; myoclonus; Alzheimer disease and other dementias increase seizure risk | MRI shows atrophy; clinical syndrome of dementia; EEG may show slowing |
Anatomical Approach to Seizure Etiology
Cortical Lesions
Brain tumor (glioma, meningioma, metastasis)
Cortical dysplasia
Stroke (ischemic or hemorrhagic)
Traumatic brain injury / contusion
Encephalitis (especially herpes simplex)
Tuberous sclerosis (cortical tubers)
Mesial Temporal Structures
Mesial temporal sclerosis
Herpes simplex encephalitis
Autoimmune limbic encephalitis
Low-grade temporal lobe tumors
Hippocampal malformations
Cavernous malformations
Diffuse / Generalized
Idiopathic generalized epilepsy (genetic)
Metabolic encephalopathy
Drug intoxication / withdrawal
Anoxic brain injury
Neurodegenerative diseases
Mitochondrial disorders
Vascular / Inflammatory
Arteriovenous malformation
Cerebral venous thrombosis
Vasculitis (primary CNS or systemic)
Posterior reversible encephalopathy syndrome
Subarachnoid hemorrhage
Cerebral amyloid angiopathy
Drug-Induced Seizures
| Drug or Drug Class | Mechanism | Characteristics | Management Notes |
|---|---|---|---|
| Bupropion | Dose-dependent lowering of seizure threshold; inhibits reuptake of dopamine and norepinephrine | Risk increases sharply above 450 mg/day; immediate-release formulation higher risk than sustained-release | Contraindicated in patients with seizure history; discontinue if seizure occurs |
| Tramadol | Lowers seizure threshold; inhibits serotonin and norepinephrine reuptake; weak opioid agonist | Risk even at therapeutic doses; increased risk with SSRIs (serotonin syndrome overlap) | Avoid in epilepsy; caution with serotonergic drugs |
| Tricyclic antidepressants | Sodium channel blockade (at high levels); anticholinergic effects | Primarily in overdose; QRS widening on ECG; anticholinergic toxidrome | Sodium bicarbonate for cardiac toxicity; benzodiazepines for seizures |
| Antipsychotics (especially clozapine) | Lowers seizure threshold via multiple mechanisms including D2 blockade and effects on GABA | Clozapine: dose-dependent, approximately 3-5% risk; rapid dose escalation increases risk | Consider prophylactic antiseizure medication with clozapine at higher doses |
| Fluoroquinolones | GABA-A receptor antagonism | Risk especially in elderly, renal impairment, concurrent NSAIDs or theophylline | Use alternatives when possible in high-risk patients |
| Carbapenems (imipenem > meropenem) | GABA-A receptor antagonism; imipenem has higher epileptogenic potential | Risk in renal impairment, CNS pathology, concurrent valproate (decreases valproate levels) | Meropenem preferred in patients with seizure risk; dose-adjust for renal function |
| Isoniazid | Depletes pyridoxine (vitamin B6), required for GABA synthesis | Seizures refractory to benzodiazepines; metabolic acidosis; in overdose or with chronic use without B6 supplementation | Pyridoxine is specific antidote; give gram-for-gram with isoniazid ingested (or 5 grams empirically) |
| Cocaine and amphetamines | Increased catecholamines; direct neurotoxicity; hyperthermia; hypertensive crisis | May cause seizures during intoxication; also risk of stroke/hemorrhage | Benzodiazepines first-line; avoid beta-blockers (unopposed alpha stimulation); cooling if hyperthermic |
| Synthetic cannabinoids | Variable and unpredictable effects; may have proconvulsant compounds | Severe presentations with agitation, psychosis, seizures; unknown specific compound often | Supportive care; benzodiazepines; may be difficult to detect on standard drug screens |
| Theophylline | Adenosine receptor antagonism; phosphodiesterase inhibition; increases catecholamines | Seizures often refractory; may occur at therapeutic levels in elderly; nausea, vomiting, arrhythmias | Check theophylline level; charcoal hemoperfusion or hemodialysis in severe toxicity |
| Lithium | Multiple mechanisms; neurotoxicity in overdose or chronic toxicity | Coarse tremor, ataxia, confusion, myoclonus; ECG changes; diabetes insipidus | Hemodialysis for severe toxicity; supportive care |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Seizure 6-48 hours after last drink + tremor + diaphoresis | Alcohol withdrawal seizure | Benzodiazepines, CIWA protocol, thiamine, monitor for delirium tremens |
| Diabetic patient + confusion + diaphoresis | Hypoglycemia | Check glucose immediately; IV dextrose if confirmed |
| Pregnant woman + hypertension + seizure | Eclampsia | Magnesium sulfate, blood pressure control, urgent obstetric consultation |
| Fever + headache + neck stiffness + seizure | Meningitis/Encephalitis | Empiric antibiotics and acyclovir; lumbar puncture if safe; imaging |
| Adolescent + seizure upon awakening + myoclonic jerks | Juvenile myoclonic epilepsy | EEG (generalized polyspike-wave); lifelong treatment usually required |
| Aura (déjà vu, rising epigastric sensation) + automatisms + confusion | Temporal lobe epilepsy | MRI (look for mesial temporal sclerosis); EEG with temporal electrodes |
| Older adult + focal seizure + progressive headaches + weight loss | Brain tumor (primary or metastatic) | MRI brain with contrast; staging workup if metastatic disease suspected |
| Post-thyroidectomy + tetany + perioral numbness + seizure | Hypocalcemia (hypoparathyroidism) | IV calcium gluconate; check calcium, PTH, magnesium; ECG for QT prolongation |
| Eyes tightly closed during event + pelvic thrusting + prolonged duration | Psychogenic nonepileptic seizure | Video-EEG monitoring; avoid escalating antiseizure medications; psychiatric referral |
| Subacute onset + psychiatric symptoms + memory problems + seizures | Autoimmune encephalitis | MRI, CSF analysis, autoimmune antibody panel; empiric immunotherapy consideration |
| Severe hypertension + headache + visual changes + posterior white matter changes on MRI | Posterior reversible encephalopathy syndrome (PRES) | Blood pressure control; remove offending agent if applicable |
| Focal seizures + ash-leaf spots + facial angiofibromas | Tuberous sclerosis | MRI (cortical tubers, subependymal nodules); genetic testing; monitor for complications |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The investigation of a new seizure aims to: (1) identify reversible or treatable causes, (2) assess for structural brain abnormalities, (3) confirm the diagnosis and classify the epilepsy syndrome if applicable, and (4) risk stratify for recurrence. A targeted, clinically guided approach avoids unnecessary testing while ensuring serious causes are not missed.
Immediate Investigations — All Patients with New Seizure
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Point-of-care glucose | Rule out hypoglycemia as cause of seizure | Less than 70 mg/dL suggests hypoglycemia as cause; less than 50 mg/dL highly likely | Check immediately — do not wait for laboratory glucose |
| Complete metabolic panel | Detect metabolic causes | Sodium less than 125 mEq/L (hyponatremia); glucose; calcium; magnesium; renal function (uremia); liver function | Hyponatremia: assess acuity before correction; Hypocalcemia: check ionized calcium, PTH, magnesium |
| Complete blood count | Screen for infection, anemia | Leukocytosis (infection); anemia; thrombocytopenia (liver disease, DIC) | Mild leukocytosis may be postictal stress response; interpret in clinical context |
| Electrocardiogram (ECG) | Identify cardiac cause of syncope mistaken for seizure; detect drug effects | Arrhythmias (especially long QT, Brugada, heart block); prolonged QTc (hypocalcemia, drugs); QRS widening (tricyclic overdose) | Especially important if event had syncopal features or patient has cardiac history |
| Urine drug screen | Detect intoxication or withdrawal | Cocaine, amphetamines, benzodiazepines, opioids, cannabis, synthetic cannabinoids (may not detect all) | Positive result does not prove causation; negative result does not exclude synthetic drugs |
| Blood alcohol level | Assess intoxication or withdrawal | Level may be low or zero in withdrawal seizures; high level may contribute but consider other causes | Withdrawal seizures typically occur as alcohol level falls, often when approaching zero |
| Antiseizure medication levels (if applicable) | Assess adherence in known epilepsy | Subtherapeutic level suggests non-adherence; elevated level suggests toxicity or drug interaction | Draw level before administering loading dose if possible |
Neuroimaging
When to Image Emergently
Obtain urgent CT head (non-contrast) in the following situations:
- Persistent altered mental status beyond expected postictal period
- New focal neurological deficit
- Recent head trauma
- Patient on anticoagulation
- Known malignancy (concern for metastases or hemorrhage)
- Immunocompromised patient (opportunistic infection, lymphoma)
- Fever with seizure (concern for CNS infection — LP may be needed after CT)
- Signs of increased intracranial pressure (papilledema, herniation signs)
- First seizure in patient over 40 years
| Modality | Indications | What It Detects | Limitations |
|---|---|---|---|
| CT head (non-contrast) | Emergency setting; rule out hemorrhage, large mass, herniation; trauma evaluation | Acute hemorrhage; large tumors; hydrocephalus; major stroke; skull fractures | Limited sensitivity for small lesions, early ischemia, mesial temporal pathology, low-grade tumors |
| MRI brain (with and without contrast) | All patients with first unprovoked seizure (unless contraindicated); preferred for epilepsy workup | Mesial temporal sclerosis; cortical dysplasia; small tumors; cavernomas; encephalitis; stroke; vascular malformations | May not be immediately available; contraindicated with some implants; requires patient cooperation (sedation may be needed) |
| Epilepsy-protocol MRI | Recurrent seizures with normal standard MRI; presurgical evaluation; suspected subtle structural cause | Subtle cortical dysplasia; small hippocampal abnormalities; fine structural detail | Requires specialized acquisition and interpretation; not available at all centers |
| CT or MR angiography | Suspected vascular cause (arteriovenous malformation, aneurysm, venous thrombosis) | Arteriovenous malformations; aneurysms; vessel occlusion; cerebral venous thrombosis | CT requires contrast; MR venography specifically for venous sinus thrombosis |
MRI Is Superior to CT for Epilepsy Evaluation
While CT is useful in the emergency setting to exclude hemorrhage and large masses, MRI is the imaging modality of choice for evaluating seizures. MRI detects many important causes of epilepsy that CT will miss, including mesial temporal sclerosis, focal cortical dysplasia, small tumors, cavernous malformations, and encephalitis. All patients with a first unprovoked seizure should eventually have an MRI, even if the initial CT was normal.
Electroencephalography (EEG)
| EEG Type | Timing and Setting | What It Detects | Practical Considerations |
|---|---|---|---|
| Routine EEG (20-40 minutes) | Outpatient; ideally within 24-48 hours of seizure for maximum yield | Interictal epileptiform discharges (spikes, sharp waves); focal or generalized slowing; classification of epilepsy syndrome | Sensitivity approximately 50% after first seizure; increases with sleep deprivation and repeat studies; normal EEG does not exclude epilepsy |
| Sleep-deprived EEG | If routine EEG is normal or nondiagnostic; patient sleeps less than 4 hours before test | Increases detection of epileptiform abnormalities by capturing natural sleep and activating discharges | Especially useful for generalized epilepsies and temporal lobe epilepsy |
| Prolonged ambulatory EEG (24-72 hours) | When routine EEG is nondiagnostic; need to capture infrequent events | Interictal and possibly ictal activity; correlates symptoms with EEG changes | Patient wears portable EEG at home; limited technical quality compared to inpatient monitoring |
| Continuous EEG (cEEG) monitoring | ICU setting; unexplained altered mental status; suspected nonconvulsive status epilepticus; after convulsive status epilepticus | Nonconvulsive seizures; nonconvulsive status epilepticus; periodic patterns (e.g., lateralized periodic discharges) | Requires specialized equipment and interpretation; essential in critically ill patients who are not waking up as expected |
| Video-EEG monitoring | Inpatient epilepsy monitoring unit; presurgical evaluation; diagnosis of suspected psychogenic nonepileptic seizures | Captures seizures on video synchronized with EEG; definitively distinguishes epileptic seizures from PNES | Gold standard for characterizing seizures; may require antiseizure medication reduction to capture events |
Interpreting EEG Results:
- Epileptiform discharges present: Strongly supports diagnosis of epilepsy; helps classify syndrome and guide treatment; increases recurrence risk after first seizure
- Focal slowing only: Suggests underlying structural abnormality in that region; obtain MRI if not already done
- Generalized slowing: Nonspecific; may indicate metabolic or toxic encephalopathy, medication effect, or postictal state
- Normal EEG: Does NOT rule out epilepsy; approximately 50% of patients with epilepsy have normal interictal routine EEG
Lumbar Puncture
When to Perform Lumbar Puncture
- Fever with seizure: Concern for meningitis or encephalitis
- Immunocompromised patient: Opportunistic CNS infections
- Persistent altered mental status: After imaging rules out mass effect
- Suspected autoimmune encephalitis: CSF pleocytosis, autoimmune antibody testing
- Suspected subarachnoid hemorrhage with negative CT: Xanthochromia in CSF
- HIV-positive patient: Cryptococcal meningitis, toxoplasmosis, lymphoma
CSF Analysis
- Opening pressure: Elevated in meningitis, idiopathic intracranial hypertension, venous sinus thrombosis
- Cell count and differential: Pleocytosis suggests infection or inflammation
- Protein: Elevated in infection, inflammation, tumor
- Glucose: Low in bacterial meningitis, TB, fungal
- Gram stain and culture: Bacterial meningitis
- HSV PCR: Herpes simplex encephalitis
- Autoimmune antibody panel: Anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-GABA-B, and others
- Cytology: Leptomeningeal carcinomatosis
Always Image Before Lumbar Puncture If:
- Focal neurological deficit
- Papilledema or signs of increased intracranial pressure
- Altered level of consciousness (GCS less than 13)
- Immunocompromised state
- History of CNS disease (mass, stroke, infection)
- New-onset seizure (within 1 week)
However, do not delay empiric antibiotics and acyclovir while waiting for imaging if meningitis or encephalitis is suspected.
Targeted Investigations by Suspected Etiology
If Suspecting Autoimmune Encephalitis
First-Line Tests
- MRI brain: May show T2/FLAIR hyperintensity in mesial temporal lobes (but may be normal)
- EEG: May show temporal slowing, extreme delta brush (anti-NMDA receptor), or epileptiform activity
- CSF analysis: Lymphocytic pleocytosis in approximately 80%; elevated protein; may have oligoclonal bands
Second-Line Tests
- Serum and CSF autoimmune antibody panel: Anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-GABA-B, anti-AMPA, anti-GAD65
- Paraneoplastic workup: CT chest/abdomen/pelvis; testicular ultrasound (teratoma in anti-NMDA receptor encephalitis); PET scan
- Pelvic ultrasound or MRI: Ovarian teratoma in young women with anti-NMDA receptor encephalitis
If Suspecting Cerebral Venous Thrombosis
First-Line Tests
- MRI brain with MR venography: Shows thrombus in venous sinuses; may show venous infarcts (often hemorrhagic, in non-arterial distribution)
- CT venography: Alternative if MRI not available; shows filling defects in sinuses
Second-Line Tests
- D-dimer: May be elevated but not specific; normal D-dimer does not rule out CVT
- Thrombophilia workup: Factor V Leiden, prothrombin gene mutation, antiphospholipid antibodies, protein C and S, antithrombin III (test after acute period)
- Pregnancy test: Pregnancy and postpartum are risk factors
If Suspecting Herpes Simplex Encephalitis
First-Line Tests
- MRI brain: T2/FLAIR hyperintensity in mesial temporal lobes, insular cortex, orbitofrontal regions (often asymmetric)
- CSF HSV PCR: Sensitivity greater than 95% after first 24-48 hours of symptoms; may be negative very early
- CSF analysis: Lymphocytic pleocytosis; elevated protein; RBCs may be present (hemorrhagic necrosis)
Second-Line Tests
- EEG: Periodic lateralized epileptiform discharges (PLEDs) over temporal regions; focal temporal slowing
- Repeat CSF HSV PCR: If initial PCR negative but clinical suspicion high; repeat in 3-7 days
Note: Do not wait for test results to start empiric acyclovir. Treatment should begin immediately if HSE is suspected.
Serum Prolactin: A Specialized Test
When Prolactin May Help
Serum prolactin can help distinguish epileptic seizures from psychogenic nonepileptic seizures (PNES) in selected cases:
- Timing: Draw 10-20 minutes after suspected event (peak at 10-20 minutes, returns to baseline by 6 hours)
- Interpretation: Elevation greater than 2 times baseline (or greater than 2-3 times upper limit of normal) supports generalized tonic-clonic or focal seizure with impaired awareness
- Limitations: Not elevated after all seizure types (especially frontal lobe seizures); may be elevated by syncope; requires baseline for comparison; not useful for status epilepticus
- Use: Primarily in epilepsy monitoring units to help interpret captured events; not routinely used in emergency department
Investigation Summary by Clinical Setting
| Setting | Essential Investigations | Consider Adding |
|---|---|---|
| Emergency Department — First Seizure | Glucose, BMP, CBC, urine drug screen, blood alcohol, ECG, CT head | LP (if fever/immunocompromised), toxicology levels, liver function tests, antiseizure medication levels (if known epilepsy) |
| Outpatient Follow-up — Post-First Seizure | MRI brain with and without contrast, routine EEG | Sleep-deprived EEG if routine EEG normal, extended EEG monitoring if diagnosis uncertain |
| ICU — Refractory Status Epilepticus | Continuous EEG, comprehensive metabolic panel, MRI when stable, LP (if infection/autoimmune suspected) | Autoimmune encephalitis panel, toxicology screen, paraneoplastic workup, genetic testing in young patients |
| Epilepsy Clinic — Recurrent Seizures | Epilepsy-protocol MRI (if standard MRI negative), video-EEG monitoring | Genetic testing, neuropsychological evaluation, PET or SPECT (presurgical evaluation), functional MRI |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Clinical decision-making in seizure management requires rapid triage to identify emergencies, systematic evaluation to determine etiology, and evidence-based decisions about initiating antiseizure therapy. This section provides practical algorithms for common clinical scenarios encountered in the family medicine and emergency setting.
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Active seizure greater than 5 minutes OR repeated seizures without recovery | EMERGENT | Status epilepticus protocol: Airway, IV access, benzodiazepine (lorazepam 4 mg IV or midazolam 10 mg IM), check glucose, prepare second-line agents |
| Seizure with fever, headache, or neck stiffness | EMERGENT | Suspect CNS infection: Empiric antibiotics and acyclovir immediately, CT head, lumbar puncture when safe |
| Seizure in pregnancy or postpartum (especially with hypertension) | EMERGENT | Assume eclampsia: Magnesium sulfate 4-6 g IV loading dose, blood pressure control, urgent obstetric consultation |
| New focal neurological deficit after seizure (not improving) | EMERGENT | Consider stroke or mass lesion: Urgent CT/MRI, neurology consultation, stroke protocol if indicated |
| Seizure following significant head trauma | EMERGENT | CT head to rule out intracranial hemorrhage, neurosurgical consultation if bleeding present |
| Patient on anticoagulation with new seizure | URGENT | CT head to rule out intracranial hemorrhage, check INR/coagulation studies, consider reversal if bleeding |
| First unprovoked seizure, now back to baseline | URGENT | Complete metabolic workup, CT head (in ED), arrange outpatient MRI and EEG, safety counseling, neurology referral |
| Known epilepsy, breakthrough seizure, back to baseline | URGENT | Check antiseizure medication levels, assess adherence, evaluate for triggers (sleep deprivation, illness, medication changes) |
| Suspected alcohol withdrawal seizure, otherwise stable | URGENT | Benzodiazepine protocol (CIWA), thiamine, monitor for progression to delirium tremens, consider admission |
| Suspected psychogenic nonepileptic seizure, patient stable | ROUTINE | Avoid unnecessary antiseizure medication escalation, arrange video-EEG monitoring, psychiatric referral |
Step 2: Status Epilepticus Treatment Algorithm
Status Epilepticus: Time-Critical Management
Status epilepticus is defined as continuous seizure activity for ≥5 minutes OR ≥2 seizures without return to baseline. Mortality is 10-20%, and neuronal injury begins after 30 minutes of continuous seizure activity. Early benzodiazepine treatment is critical.
| Time | Phase | Action |
|---|---|---|
| 0-5 minutes | Stabilization |
|
| 5-20 minutes | First-line therapy |
|
| 20-40 minutes | Second-line therapy (if seizures persist) |
|
| 40+ minutes | Refractory status epilepticus |
|
Step 3: First Unprovoked Seizure — To Treat or Not to Treat?
The Key Question: Should antiseizure medication be started after a first unprovoked seizure?
The decision depends on the estimated risk of recurrence. Overall risk after a single unprovoked seizure is approximately 40-50% within 2 years. Treatment reduces recurrence risk by approximately 50% but does not alter long-term remission rates. The decision should be individualized based on risk factors and patient preferences.
| Clinical Scenario | Estimated Recurrence Risk | Recommendation |
|---|---|---|
| First seizure + normal EEG + normal MRI + no risk factors | Approximately 25-30% over 2 years | Treatment optional; discuss risks and benefits with patient; many choose to defer treatment and observe |
| First seizure + epileptiform abnormalities on EEG | Approximately 60-70% over 2 years | Meets ILAE criteria for epilepsy diagnosis; recommend treatment |
| First seizure + structural lesion on MRI (prior stroke, tumor, etc.) | Approximately 60-70% over 2 years | Meets ILAE criteria for epilepsy diagnosis; recommend treatment |
| First seizure + Todd’s paralysis or other postictal focal deficit | Higher than baseline | Suggests focal onset; recommend MRI; likely to benefit from treatment |
| First seizure + family history of epilepsy + EEG abnormalities | Approximately 60% or higher | Consider treatment, especially if patient has high-risk occupation or driving needs |
| Two or more unprovoked seizures (more than 24 hours apart) | Approximately 70-80% | Epilepsy diagnosis established; antiseizure medication recommended |
Factors Favoring Treatment After First Seizure
- Abnormal EEG with epileptiform discharges
- Structural brain lesion on MRI
- Nocturnal seizure (higher recurrence risk)
- Patient preference (anxiety about recurrence, driving needs)
- High-risk occupation (pilot, commercial driver, working at heights)
- Status epilepticus as initial presentation
- Prior brain injury (stroke, trauma, encephalitis)
Step 4: Choosing Initial Antiseizure Medication
| Seizure Type / Syndrome | First-Line Options | Medications to AVOID |
|---|---|---|
| Focal seizures (with or without secondary generalization) | Levetiracetam, Lamotrigine, Carbamazepine, Oxcarbazepine, Lacosamide | Ethosuximide (not effective for focal) |
| Generalized tonic-clonic seizures (primary generalized) | Levetiracetam, Lamotrigine, Valproate | Carbamazepine, Oxcarbazepine, Phenytoin (may worsen some generalized epilepsies) |
| Absence seizures | Ethosuximide (first-line if absence only), Valproate, Lamotrigine | Carbamazepine, Phenytoin, Gabapentin, Tiagabine (may worsen absences) |
| Juvenile myoclonic epilepsy | Valproate, Levetiracetam, Lamotrigine (use cautiously — may worsen myoclonus) | Carbamazepine, Oxcarbazepine, Phenytoin, Gabapentin (worsen myoclonus) |
| Unknown seizure type (unable to classify) | Levetiracetam, Lamotrigine, Valproate (broad-spectrum options) | Narrow-spectrum medications until classification clarified |
| Women of childbearing potential | Levetiracetam, Lamotrigine, Oxcarbazepine (lower teratogenic risk) | Valproate (contraindicated — high teratogenic risk, developmental effects) |
| Elderly patients | Levetiracetam, Lamotrigine, Lacosamide (fewer drug interactions, better tolerability) | Enzyme-inducing drugs if on multiple medications (phenytoin, carbamazepine, phenobarbital) |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient seizes in my office? | Protect from injury (move objects away, cushion head); turn on side if possible; do NOT restrain or put anything in mouth; note time | Call emergency services if seizure lasts greater than 5 minutes or patient doesn’t regain consciousness; stay with patient; provide information to EMS |
| Known epilepsy patient has breakthrough seizure? | Check medication adherence; check antiseizure medication levels; evaluate for triggers (sleep deprivation, illness, new medications, alcohol) | If levels subtherapeutic — reload and reinforce adherence; if therapeutic — consider dose increase or add-on therapy; neurology follow-up |
| Witnessed event unclear if seizure or syncope? | Detailed history from patient AND witness; review event characteristics (prodrome, duration, postictal state, tongue bite location) | ECG and orthostatic vitals for all; EEG if seizure suspected; echocardiogram and Holter if cardiac syncope suspected; consider tilt table |
| Suspected psychogenic nonepileptic seizures (PNES)? | Do NOT escalate antiseizure medications; maintain supportive, non-judgmental approach; avoid excessive emergency interventions | Refer for video-EEG monitoring for definitive diagnosis; psychiatric evaluation; explain that PNES is real and treatable (not “faking”) |
| Patient asks about driving after seizure? | Advise patient not to drive until cleared; explain legal requirements (vary by jurisdiction — typically 3-12 months seizure-free) | Document counseling; know local regulations; provide written information; follow up to determine when driving can resume |
| Female patient with epilepsy wants to become pregnant? | Review current medications for teratogenic risk; ensure high-dose folic acid (4 mg daily); optimize seizure control before conception | Switch away from valproate if possible; refer to high-risk obstetrics and epilepsy specialist; discuss risks of seizures during pregnancy |
| Older adult with new seizure and no obvious cause? | Low threshold for imaging (CT now, MRI as outpatient); consider stroke, tumor, metabolic causes, medication effect | MRI with contrast to evaluate for tumor or prior stroke; EEG; review all medications for seizure-lowering threshold |
| Patient not improving as expected after seizure? | Consider nonconvulsive status epilepticus; obtain urgent EEG (continuous monitoring if available) | If nonconvulsive status confirmed — treat aggressively; if EEG negative — evaluate for other causes of altered mental status |
Safety Counseling and Driving Restrictions
Essential Safety Counseling After Seizure
All patients with a new seizure should receive counseling on safety precautions:
- Driving: Advise against driving until meeting jurisdictional requirements (typically 3-12 months seizure-free depending on location); document this conversation
- Bathing: Showers preferred over baths (drowning risk); avoid locked bathroom doors
- Swimming: Never swim alone; always with supervision and informed companion
- Heights and machinery: Avoid ladders, scaffolding, operating heavy machinery until seizure-free
- Supervision: Consider having someone check on patient regularly, especially if living alone
- Medication adherence: Emphasize importance of not missing doses; discuss pill organizers, alarms
- Lifestyle factors: Adequate sleep, limit alcohol, avoid known triggers
- SUDEP counseling: Discuss risk of Sudden Unexpected Death in Epilepsy; risk reduced with good seizure control and medication adherence
When to Refer to Neurology / Epilepsy Specialist
Urgent Referral
- Status epilepticus or repeated seizures
- Seizure with focal neurological deficit
- Suspected CNS infection or autoimmune encephalitis
- Structural lesion on imaging
- Pregnancy with seizure
- Uncertain diagnosis (seizure vs. mimic)
Routine Referral
- First unprovoked seizure (for EEG, MRI interpretation, treatment decisions)
- Breakthrough seizures despite treatment
- Medication side effects requiring change
- Drug-resistant epilepsy (failure of two appropriate medications)
- Consideration of medication withdrawal after prolonged seizure freedom
- Women with epilepsy planning pregnancy
- Presurgical evaluation for refractory epilepsy
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- First, confirm it was a seizure: Up to 20-30% of patients referred for seizures have an alternative diagnosis. Detailed history from patient AND witness is essential. Key features favoring seizure include lateral tongue biting, postictal confusion lasting greater than 5 minutes, and loss of consciousness with tonic-clonic movements.
- Always check glucose immediately: Hypoglycemia is a rapidly reversible cause of seizures. Point-of-care glucose should be checked in every patient with seizure or altered mental status.
- Distinguish provoked from unprovoked seizures: Provoked seizures (due to acute metabolic derangement, intoxication, withdrawal, acute brain injury) often do not require long-term antiseizure medication. Treat the underlying cause.
- Status epilepticus is a medical emergency: Defined as seizure activity for ≥5 minutes or repeated seizures without return to baseline. Early benzodiazepine treatment is critical; delayed treatment reduces effectiveness.
- MRI is superior to CT for epilepsy evaluation: While CT excludes hemorrhage and large masses emergently, MRI detects many important causes of epilepsy (mesial temporal sclerosis, cortical dysplasia, small tumors) that CT misses.
- A normal EEG does not rule out epilepsy: Approximately 50% of patients with epilepsy have a normal routine interictal EEG. If clinical suspicion is high, pursue sleep-deprived EEG or prolonged monitoring.
- Treatment after first seizure is individualized: Overall recurrence risk after first unprovoked seizure is approximately 40-50%. Risk is higher with abnormal EEG or structural lesion (approximately 60-70%), meeting criteria for epilepsy diagnosis after a single seizure.
- Choose antiseizure medication based on seizure type and patient factors: Broad-spectrum agents (levetiracetam, lamotrigine, valproate) are safe for unknown or generalized seizure types. Avoid valproate in women of childbearing potential. Avoid sodium channel blockers in generalized epilepsies.
- Safety counseling is mandatory: All patients must be counseled about driving restrictions, water safety, and activity modifications. Document this conversation. Know your jurisdiction’s driving laws.
- Consider nonconvulsive status epilepticus in unexplained altered mental status: If a patient is not improving as expected after a seizure, or has unexplained encephalopathy, obtain EEG to rule out ongoing nonconvulsive seizures.
Quick Reference Algorithm
Systematic Approach to New Seizure:
- Stabilize: Airway, breathing, circulation; protect patient from injury; check glucose immediately; give benzodiazepine if seizing greater than 5 minutes
- Confirm seizure: Obtain detailed history from patient AND witness; distinguish from syncope, PNES, other mimics using key features (tongue biting, postictal state, eye position, duration)
- Identify provoked causes: Complete metabolic panel, urine drug screen, blood alcohol; evaluate for infection, stroke, trauma, medication effects, withdrawal
- Image the brain: CT head emergently if red flags present; MRI for all patients with first unprovoked seizure (outpatient if stable)
- Obtain EEG: Routine EEG within 24-48 hours for maximum yield; sleep-deprived or prolonged EEG if initial study nondiagnostic
- Risk stratify and decide on treatment: Assess recurrence risk based on EEG, imaging, and clinical factors; discuss treatment options with patient; consider deferring treatment if low risk
- Counsel and educate: Driving restrictions, water safety, activity modifications, medication adherence, trigger avoidance (sleep deprivation, alcohol); provide written materials
- Arrange follow-up: Neurology referral for most patients with first seizure; earlier if diagnostic uncertainty, structural lesion, or treatment required